New Delhi: Morepen Laboratories Limited has received U. S. Food and drug Administration (USFDA) approval for its anti-allergy drug Fexofinadine Hydrochloride that is marketed in India under the.
NEW DELHI, Dec 3: Drug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofinadine Hydrochloride in the American market. The company sells the product in India under the brand name Allegra. Morepen’s product is the generic version of Sanofi Aventis’ anti- allergy drug. Fexofinadine is the most widely used, second generation antihistamine drug for the treatment of allergy symptoms and hay fever. In a statement, the company said […]
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
On Friday, the indices opened higher and ended with loss. On the National Stock Exchange (NSE), 1,074 stocks advanced, 924 declined, and 74 remained unchanged with advance decline ratio of 1.16.